62 related articles for article (PubMed ID: 15551306)
1. Alterations of cancer-related genes in soft tissue sarcomas: hypermethylation of RASSF1A is frequently detected in leiomyosarcoma and associated with poor prognosis in sarcoma.
Seidel C; Bartel F; Rastetter M; Bluemke K; Wurl P; Taubert H; Dammann R
Int J Cancer; 2005 Apr; 114(3):442-7. PubMed ID: 15551306
[TBL] [Abstract][Full Text] [Related]
2. Can DNA Methylation Profiling Classify Histologic Subtypes and Grades in Soft Tissue Sarcoma?
Kim H; Joo MW; Yoon J; Park HS; Kim JH; Lee JH; Kim SH; Lee SK; Chung YG; Cho YJ
Clin Orthop Relat Res; 2024 Mar; 482(6):1028-37. PubMed ID: 38517415
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Effects of RASSF1A, BRCA1, APC, and p16 Promoter Methylation in Ovarian Cancer: A Meta-Analysis.
Chen C; Zhu Y; Zhang H; Xiao L
Gynecol Obstet Invest; 2024 Apr; ():1-13. PubMed ID: 38615670
[TBL] [Abstract][Full Text] [Related]
4. Sex-dependent Prognosis of Patients with Advanced Soft Tissue Sarcoma.
Pan M; Zhou MY; Jiang C; Zhang Z; Bui NQ; Bien J; Siy A; Achacoso N; Solorzano AV; Tse P; Chung E; Thomas S; Habel LA; Ganjoo KN
Clin Cancer Res; 2024 Jan; 30(2):413-419. PubMed ID: 37831066
[TBL] [Abstract][Full Text] [Related]
5. Impact of anthracycline-based chemotherapy on RB1 gene methylation in peripheral blood leukocytes and biomarkers of oxidative stress and inflammation in sarcoma patients.
Pokupec Bilić A; Bilić I; Radić Brkanac S; Simetić L; Blažičević K; Herceg D; Mikloš M; Tonković Đurišević I; Domijan AM
Clin Transl Oncol; 2024 Jun; 26(6):1508-1518. PubMed ID: 38310203
[TBL] [Abstract][Full Text] [Related]
6. Superoxide Dismutase Mimetic Avasopasem Manganese Enhances Radiation Therapy Effectiveness in Soft Tissue Sarcomas and Accelerates Wound Healing.
Zaher A; Mapuskar KA; Petronek MS; Tanas MR; Isaacson AL; Dodd RD; Milhem M; Furqan M; Spitz DR; Miller BJ; Beardsley RA; Allen BG
Antioxidants (Basel); 2024 May; 13(5):. PubMed ID: 38790692
[TBL] [Abstract][Full Text] [Related]
7. Immune evasion in lung metastasis of leiomyosarcoma: upregulation of EPCAM inhibits CD8
Kanahori M; Shimada E; Matsumoto Y; Endo M; Fujiwara T; Nabeshima A; Hirose T; Kawaguchi K; Oyama R; Oda Y; Nakashima Y
Br J Cancer; 2024 Apr; 130(7):1083-1095. PubMed ID: 38291183
[TBL] [Abstract][Full Text] [Related]
8. Ki-67 and CD100 immunohistochemical expression is associated with local recurrence and poor prognosis in soft tissue sarcomas, respectively.
Campos M; DE Campos SG; Ribeiro GG; Eguchi FC; Silva SR; DE Oliveira CZ; DA Costa AM; Curcelli EC; Nunes MC; Penna V; Longatto-Filho A
Oncol Lett; 2013 May; 5(5):1527-1535. PubMed ID: 23759874
[TBL] [Abstract][Full Text] [Related]
9. Comparative oncology reveals DNMT3B as a molecular vulnerability in undifferentiated pleomorphic sarcoma.
Fuller AM; DeVine A; Murazzi I; Mason NJ; Weber K; Eisinger-Mathason TSK
Cell Oncol (Dordr); 2022 Dec; 45(6):1277-1295. PubMed ID: 36181640
[TBL] [Abstract][Full Text] [Related]
10. Integrated Analysis of Nine Prognostic RNA-Binding Proteins in Soft Tissue Sarcoma.
Lin LL; Liu ZZ; Tian JZ; Zhang X; Zhang Y; Yang M; Zhong HC; Fang W; Wei RX; Hu C
Front Oncol; 2021; 11():633024. PubMed ID: 34026613
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of a Three-DNA Methylation Biomarker in Patients with Soft Tissue Sarcoma.
Chen Y; Zhu R; Chen M; Guo W; Yang X; Xu XJ; Zhu L
J Oncol; 2020; 2020():8106212. PubMed ID: 32508922
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic therapy of novel tumour suppressor ZAR1 and its cancer biomarker function.
Deutschmeyer V; Breuer J; Walesch SK; Sokol AM; Graumann J; Bartkuhn M; Boettger T; Rossbach O; Richter AM
Clin Epigenetics; 2019 Dec; 11(1):182. PubMed ID: 31801617
[TBL] [Abstract][Full Text] [Related]
13. Liquid Biopsy as a Tool for Differentiation of Leiomyomas and Sarcomas of Corpus Uteri.
Dvorská D; Škovierová H; Braný D; Halašová E; Danková Z
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387281
[TBL] [Abstract][Full Text] [Related]
14. Impact of Natural Compounds on DNA Methylation Levels of the Tumor Suppressor Gene RASSF1A in Cancer.
Dammann RH; Richter AM; Jiménez AP; Woods M; Küster M; Witharana C
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29039788
[TBL] [Abstract][Full Text] [Related]
15. Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma.
Que Y; Qiu H; Li Y; Chen Y; Xiao W; Zhou Z; Zhang X
BMC Cancer; 2015 Oct; 15():648. PubMed ID: 26432433
[TBL] [Abstract][Full Text] [Related]
16. A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas.
Deel MD; Li JJ; Crose LE; Linardic CM
Front Oncol; 2015; 5():190. PubMed ID: 26389076
[TBL] [Abstract][Full Text] [Related]
17. Malignant tumors of the uterine corpus: molecular background of their origin.
Brany D; Dvorska D; Nachajova M; Slavik P; Burjanivova T
Tumour Biol; 2015 Sep; 36(9):6615-21. PubMed ID: 26307392
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of RASSF1A methylation in human malignancies.
Grawenda AM; O'Neill E
Br J Cancer; 2015 Jul; 113(3):372-81. PubMed ID: 26158424
[TBL] [Abstract][Full Text] [Related]
19. Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis.
Danielsen SA; Lind GE; Kolberg M; Høland M; Bjerkehagen B; Sundby Hall K; van den Berg E; Mertens F; Smeland S; Picci P; Lothe RA
Neuro Oncol; 2015 Jan; 17(1):63-9. PubMed ID: 25038505
[TBL] [Abstract][Full Text] [Related]
20. Integrative DNA methylation and gene expression analysis in high-grade soft tissue sarcomas.
Renner M; Wolf T; Meyer H; Hartmann W; Penzel R; Ulrich A; Lehner B; Hovestadt V; Czwan E; Egerer G; Schmitt T; Alldinger I; Renker EK; Ehemann V; Eils R; Wardelmann E; Büttner R; Lichter P; Brors B; Schirmacher P; Mechtersheimer G
Genome Biol; 2013 Dec; 14(12):r137. PubMed ID: 24345474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
